A comparison of criteria to identify inflammatory breast cancer cases from medical records and the surveillance, epidemiology and end results data base, 2007-2009

Kelly A. Hirko, Amr S. Soliman, Mousumi Banerjee, Julie Ruterbusch, Joe B. Harford, Sofia D. Merajver, Kendra Schwartz

Research output: Contribution to journalReview article

6 Citations (Scopus)

Abstract

Inflammatory breast cancer (IBC) is a relatively rare and extremely aggressive form of breast cancer that is diagnosed clinically. Standardization of clinical diagnoses is challenging, both nationally and internationally; moreover, IBC coding definitions used by registries have changed over time. This study aimed to compare diagnostic factors of IBC reported in a U.S. Surveillance, Epidemiology, and End Results (SEER) registry to clinical criteria found in the medical records of all invasive breast cancer cases at a single institution. We conducted a medical record review of all female invasive breast cancers (n = 915) seen at an NCI-designated comprehensive cancer center in Detroit from 2007 to 2009. IBC cases were identified based on the presence of the main clinical characteristics of the disease (erythema, edema, peau d'orange). We compared the proportion of IBC out of all breast cancers, using these clinical criteria and the standard SEER IBC codes. In the reviewed cases, the clinical criteria identified significantly more IBC cases (n = 74, 8.1%) than the standard IBC SEER definition (n = 19, 2.1%; p < 0.0001). No IBC cases were identified in the cancer center records using the SEER pathologic coding, which requires the diagnosis of inflammatory carcinoma on the pathology report, a notation that is rarely made. Emphasis must be placed on the documentation of clinical and pathologic characteristics of IBC in the medical record, so that analysis of putative IBC subtypes will be possible. Our results indicate the need for a consensus on the definition of IBC to be utilized in future research.

Original languageEnglish (US)
Pages (from-to)185-191
Number of pages7
JournalBreast Journal
Volume20
Issue number2
DOIs
StatePublished - Jan 1 2014

Fingerprint

Inflammatory Breast Neoplasms
Medical Records
Epidemiology
Databases
Breast Neoplasms
Registries
Erythema
Documentation

Keywords

  • SEER
  • diagnostic criteria
  • inflammatory breast cancer

ASJC Scopus subject areas

  • Internal Medicine
  • Surgery
  • Oncology

Cite this

A comparison of criteria to identify inflammatory breast cancer cases from medical records and the surveillance, epidemiology and end results data base, 2007-2009. / Hirko, Kelly A.; Soliman, Amr S.; Banerjee, Mousumi; Ruterbusch, Julie; Harford, Joe B.; Merajver, Sofia D.; Schwartz, Kendra.

In: Breast Journal, Vol. 20, No. 2, 01.01.2014, p. 185-191.

Research output: Contribution to journalReview article

Hirko, Kelly A. ; Soliman, Amr S. ; Banerjee, Mousumi ; Ruterbusch, Julie ; Harford, Joe B. ; Merajver, Sofia D. ; Schwartz, Kendra. / A comparison of criteria to identify inflammatory breast cancer cases from medical records and the surveillance, epidemiology and end results data base, 2007-2009. In: Breast Journal. 2014 ; Vol. 20, No. 2. pp. 185-191.
@article{9e48686e5c5c4cf9b548512c9c44066e,
title = "A comparison of criteria to identify inflammatory breast cancer cases from medical records and the surveillance, epidemiology and end results data base, 2007-2009",
abstract = "Inflammatory breast cancer (IBC) is a relatively rare and extremely aggressive form of breast cancer that is diagnosed clinically. Standardization of clinical diagnoses is challenging, both nationally and internationally; moreover, IBC coding definitions used by registries have changed over time. This study aimed to compare diagnostic factors of IBC reported in a U.S. Surveillance, Epidemiology, and End Results (SEER) registry to clinical criteria found in the medical records of all invasive breast cancer cases at a single institution. We conducted a medical record review of all female invasive breast cancers (n = 915) seen at an NCI-designated comprehensive cancer center in Detroit from 2007 to 2009. IBC cases were identified based on the presence of the main clinical characteristics of the disease (erythema, edema, peau d'orange). We compared the proportion of IBC out of all breast cancers, using these clinical criteria and the standard SEER IBC codes. In the reviewed cases, the clinical criteria identified significantly more IBC cases (n = 74, 8.1{\%}) than the standard IBC SEER definition (n = 19, 2.1{\%}; p < 0.0001). No IBC cases were identified in the cancer center records using the SEER pathologic coding, which requires the diagnosis of inflammatory carcinoma on the pathology report, a notation that is rarely made. Emphasis must be placed on the documentation of clinical and pathologic characteristics of IBC in the medical record, so that analysis of putative IBC subtypes will be possible. Our results indicate the need for a consensus on the definition of IBC to be utilized in future research.",
keywords = "SEER, diagnostic criteria, inflammatory breast cancer",
author = "Hirko, {Kelly A.} and Soliman, {Amr S.} and Mousumi Banerjee and Julie Ruterbusch and Harford, {Joe B.} and Merajver, {Sofia D.} and Kendra Schwartz",
year = "2014",
month = "1",
day = "1",
doi = "10.1111/tbj.12234",
language = "English (US)",
volume = "20",
pages = "185--191",
journal = "Breast Journal",
issn = "1075-122X",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - A comparison of criteria to identify inflammatory breast cancer cases from medical records and the surveillance, epidemiology and end results data base, 2007-2009

AU - Hirko, Kelly A.

AU - Soliman, Amr S.

AU - Banerjee, Mousumi

AU - Ruterbusch, Julie

AU - Harford, Joe B.

AU - Merajver, Sofia D.

AU - Schwartz, Kendra

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Inflammatory breast cancer (IBC) is a relatively rare and extremely aggressive form of breast cancer that is diagnosed clinically. Standardization of clinical diagnoses is challenging, both nationally and internationally; moreover, IBC coding definitions used by registries have changed over time. This study aimed to compare diagnostic factors of IBC reported in a U.S. Surveillance, Epidemiology, and End Results (SEER) registry to clinical criteria found in the medical records of all invasive breast cancer cases at a single institution. We conducted a medical record review of all female invasive breast cancers (n = 915) seen at an NCI-designated comprehensive cancer center in Detroit from 2007 to 2009. IBC cases were identified based on the presence of the main clinical characteristics of the disease (erythema, edema, peau d'orange). We compared the proportion of IBC out of all breast cancers, using these clinical criteria and the standard SEER IBC codes. In the reviewed cases, the clinical criteria identified significantly more IBC cases (n = 74, 8.1%) than the standard IBC SEER definition (n = 19, 2.1%; p < 0.0001). No IBC cases were identified in the cancer center records using the SEER pathologic coding, which requires the diagnosis of inflammatory carcinoma on the pathology report, a notation that is rarely made. Emphasis must be placed on the documentation of clinical and pathologic characteristics of IBC in the medical record, so that analysis of putative IBC subtypes will be possible. Our results indicate the need for a consensus on the definition of IBC to be utilized in future research.

AB - Inflammatory breast cancer (IBC) is a relatively rare and extremely aggressive form of breast cancer that is diagnosed clinically. Standardization of clinical diagnoses is challenging, both nationally and internationally; moreover, IBC coding definitions used by registries have changed over time. This study aimed to compare diagnostic factors of IBC reported in a U.S. Surveillance, Epidemiology, and End Results (SEER) registry to clinical criteria found in the medical records of all invasive breast cancer cases at a single institution. We conducted a medical record review of all female invasive breast cancers (n = 915) seen at an NCI-designated comprehensive cancer center in Detroit from 2007 to 2009. IBC cases were identified based on the presence of the main clinical characteristics of the disease (erythema, edema, peau d'orange). We compared the proportion of IBC out of all breast cancers, using these clinical criteria and the standard SEER IBC codes. In the reviewed cases, the clinical criteria identified significantly more IBC cases (n = 74, 8.1%) than the standard IBC SEER definition (n = 19, 2.1%; p < 0.0001). No IBC cases were identified in the cancer center records using the SEER pathologic coding, which requires the diagnosis of inflammatory carcinoma on the pathology report, a notation that is rarely made. Emphasis must be placed on the documentation of clinical and pathologic characteristics of IBC in the medical record, so that analysis of putative IBC subtypes will be possible. Our results indicate the need for a consensus on the definition of IBC to be utilized in future research.

KW - SEER

KW - diagnostic criteria

KW - inflammatory breast cancer

UR - http://www.scopus.com/inward/record.url?scp=84896272635&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896272635&partnerID=8YFLogxK

U2 - 10.1111/tbj.12234

DO - 10.1111/tbj.12234

M3 - Review article

VL - 20

SP - 185

EP - 191

JO - Breast Journal

JF - Breast Journal

SN - 1075-122X

IS - 2

ER -